Novartis - Latest News on Novartis | Read Breaking News on Zee News

New drug target to help fight malaria identified

Last Updated: Thursday, November 28, 2013, 13:22

A team of researchers has identified a key metabolic enzyme that is required by the common malaria parasites at all stages of its life cycle for survival in humans.

Eighth Princeton student diagnosed with meningitis

Last Updated: Saturday, November 23, 2013, 10:04

An eighth Princeton University student has been diagnosed with meningitis, a potentially fatal infection that causes swelling of the brain and spinal cord, a university spokesman said on Friday.

Novartis muscle wasting drug gets `breakthrough` status

Last Updated: Wednesday, August 21, 2013, 00:52

Novartis said on Tuesday U.S. regulators have granted breakthrough therapy status for its investigational compound bimagrumab for the potential treatment of patients with sporadic inclusion body myositis (sIBM).

Novartis, BioE join hands for typhoid, paratyphoid vaccines

Last Updated: Monday, July 08, 2013, 14:25

Switzerland-based drug major Novartis today said it has entered into a development and licensing agreement with Biological E (BioE) for two vaccines against typhoid and paratyphoid fevers.

US sues Novartis for paying kickbacks

Last Updated: Saturday, April 27, 2013, 13:50

The US Justice Department on Friday accused drug maker Novartis of paying kickbacks to doctors to prescribe the company`s drugs over rival products.

Pharma giant Novartis working on H7N9 vaccine

Last Updated: Thursday, April 25, 2013, 23:23

Swiss pharmaceuticals giant Novartis is researching a vaccine for the H7N9 strain of bird flu, its chief executive said today, amid fears that the disease could mutate into a form that spreads among people.

New jab for `deadly` meningitis could save thousands of lives

Last Updated: Wednesday, January 23, 2013, 13:06

A vaccine against a deadly form of meningitis has been approved for use in the UK.

SC again asks Novartis to cut cancer drug price

Last Updated: Wednesday, September 12, 2012, 20:49

The Supreme Court Wednesday once again asked pharma company Novartis to scale down the price of its cancer drug Glivec, made from compound imatinib mesylate.

First Prev 1 2 Next Last